Tag: Valbenazine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Valbenazine

Tardive Dyskinesia (TD) Treatment Market Size 2020-2026 Review, Key Findings, Growth Strategy ...

Added to Collection on: 2020-11-29 15:33:08

Tags for this article:

Neurological disorders
Branches of biology
Syndromes
Tardive dyskinesia
Health
Business process
Valbenazine
Neurocrine Biosciences
Tardive
Market research

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Trims Neurocrine Biosciences (NASDAQ:NBIX) Target Price to $121.00

Added to Collection on: 2020-12-16 18:10:59

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Neurocrine Biosciences
Elagolix
Valbenazine
Neurocrine
Stock
Share
Short

Click the tags to see associated articles and topics

View Article Details
A closely watched schizophrenia drug fails key test

Added to Collection on: 2021-03-02 17:15:00

Tags for this article:

Neurocrine Biosciences
Branches of biology
Psychiatry
Valbenazine
Tardive dyskinesia
Schizophrenia
Abnormal psychology
Neurocrine

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of ...

Added to Collection on: 2021-04-08 20:03:45

Tags for this article:

Neurological disorders
Drugs
Branches of biology
Catecholamines
Parkinson's disease
Combination drugs
Neurocrine Biosciences
Tardive dyskinesia
Valbenazine
Carbidopa/levodopa
L-DOPA
Dyskinesia
Parkinson
United States
Neurocrine Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Downgraded by Zacks Investment Research

Added to Collection on: 2021-04-11 04:41:15

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Share
Stock
Short

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Zacks Investment Research

Added to Collection on: 2021-04-14 07:18:45

Tags for this article:

Financial markets
Financial economics
Finance
Equity securities
Stock market
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Stock
Short
Share

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to "Overweight" by Barclays

Added to Collection on: 2021-05-12 12:56:15

Tags for this article:

Organic compounds
Financial markets
Finance
Neurocrine Biosciences
Elagolix
Valbenazine
Neurocrine
Stock
Short
Price?earnings ratio

Click the tags to see associated articles and topics

View Article Details
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Expected to Announce Quarterly Sales of $279.51 ...

Added to Collection on: 2021-05-18 06:42:32

Tags for this article:

Organic compounds
Finance
Economy
Neurocrine Biosciences
Elagolix
Neurocrine
Valbenazine
Stock
ANGI Homeservices
Securities research
Neurocrine Biosciences Inc.
Zacks Investment Research

Click the tags to see associated articles and topics

View Article Details
Analysts' Weekly Ratings Updates for Neurocrine Biosciences (NBIX) - ETF Daily News

Added to Collection on: 2021-12-28 13:28:34

Tags for this article:

Drugs
Neurocrine Biosciences
Neurocrine
Valbenazine
Endocrine system
Securities research

Click the tags to see associated articles and topics

View Article Details
Is Tardive Dyskinesia Reversible? How to Reduce Symptoms - Verywell Health

Added to Collection on: 2022-03-08 16:41:02

Tags for this article:

Drugs
Clinical medicine
Medicine
Syndromes
Neurological disorders
Tardive dyskinesia
Typical antipsychotic
Atypical antipsychotic
Antipsychotic
Valbenazine
Psychosis
Extrapyramidal symptoms

Click the tags to see associated articles and topics

View Article Details